ArticleMolecular therapy. Methods & clinical development2015

Preclinical safety and efficacy studies with an affinity-enhanced epithelial junction opener and PEGylated liposomal doxorubicin.

Maximilian Richter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.